Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy

NCT04582955 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Triple-negative Breast Cancer

Interventions

DRUG: Chidamide in combination with chemotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital